Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2019/05/019146
CTRI/2019/05/019146Not yet recruitingPhase 1

Phase I study of radiotherapy dose escalation using 68 Ga-Pentixafor PET/CT Scan in Glioblastoma patients

one0 sites0 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor
one
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Biopsy Proven case of GBM
  • •Age >= 18 years, < 70 years
  • •Karnofsky Performance Status >= 60
  • •Adequate bone marrow reserve

Exclusion Criteria

  • •Age < 18 years
  • •H/o prior malignancy
  • •Unwilling for written informed consent and follow-up
  • •Major medical illness or psychiatric impairment that will prevent completion of the protocol
  • •or would interfere with follow-up

Investigators

Sponsor
one

Similar Trials

Not yet recruiting
Not Applicable
Phase I study of radiotherapy dose escalation on the 18F-FDG-PET avid region of the primary tumor in locally advanced oropharynx and oral cavity tumors eligible for concurrent chemoradiation.Cancer of the mouth and throatoropharynx/oral cavity carcinoma`s10017991
NL-OMON33780Antoni van Leeuwenhoek Ziekenhuis30
Active, not recruiting
Phase 1
Radiodynamic therapy (RDT) with Gliolan in patients with first recurrence of brain tumorrecurrence of glioblastomaMedDRA version: 20.0Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2021-004631-92-DEWestfälische Wilhelms-Universität Münster, C/o Universitätsklinikum Münster Geschäftsbereich Recht u. Drittmittel33
Active, not recruiting
Not Applicable
Pilot study of dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus - SPOTPhase II study of dose-intensified radiation therapy based on PET/CT-Planning in combination with induction- and concurrent chemotherapy in locally advanced squamous cell carcinomas (uT3/T4) of the esophagus
EUCTR2005-006097-10-DEniversitätsklinikum Essen41
Active, not recruiting
Phase 1
Study of radiotherapy dose escalation with Intensity Modulated Radiation Therapy (IMRT) and synchronous Cetuximab for intermediate stage head and neck cancer - INTENSE
EUCTR2007-000741-36-GBChristie Hospital NHS Trust28
Completed
Phase 1
Phase I radiaition dose escalation study of intensity-modulated radiotherapy with end-exhalation breath-hold technique, combined with full-dose gemcitabine for patients with locally advanced pancreatic cancer.Pancreatic cancer
JPRN-UMIN000004589Department of Therapeutic Radiology, Kyoto University Hospital18